EC Number   |
Application |
Reference |
|---|
   2.7.11.15 | biotechnology |
engineering of a GRK2 mutant sensitive to a specific inhibitor |
662417 |
| 2.7.11.15 | diagnostics |
GRK2 levels in heart and peripheral lymphocytes correlate well, therefore the lymphocytic enzyme level might be a very suitable marker for determination for the sympathetic drive to heart failure during clinical course and treatment of human congestive heart failure patients |
661495 |
| 2.7.11.15 | medicine |
effectiveness of in vivo applications of beta-ARK 1-targeted gene therapy at ameliorating heart failure, beta-ARK 1 upregulation often precedes the development of measurable heart failure and may represent an indicator for cardiac injury and potential therapeutic intervention prior to clinical dysfunction |
645016 |
| 2.7.11.15 | medicine |
heart failure: therapeutic strategy by manipulating beta-AR signaling, specifically through the inhibition of beta-ARK 1, elevated levels of beta-ARK 1 are an early ubiquitous consequence of myocardial injury |
645016 |
